Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,250 Reduced 0.02% |
$554,692
$246.53 p/Share
|
Oct 17
2025 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,250 Added 0.02% |
$363,375
$161.5 p/Share
|
Oct 17
2025 |
|
APDN
|
Clay Shorrock
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 49.99% |
-
|
Oct 17
2025 |
|
APDN
|
Judith Murrah
Director |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
AREC
|
Golden Properties Ltd. |
SELL
Open market or private sale
|
Direct | 980,000 Reduced 7.91% |
$3,978,799
$4.06 p/Share
|
Oct 17
2025 |
|
TENB
|
Barron Anschutz |
SELL
Open market or private sale
|
Direct | 976 Reduced 1.56% |
$28,401
$29.1 p/Share
|
Oct 17
2025 |
|
APDN
|
Yacov A Shamash
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
CNS
|
Michael T. Donohue
Interim CFO, SVP |
BUY
Grant, award, or other acquisition
|
Direct | 2,154 Added 7.65% |
-
|
Oct 17
2025 |
|
APDN
|
Elizabeth M. Ferguson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
APDN
|
Beth Jantzen
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 18,691 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Robert B Catell
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,156,801
$150.92 p/Share
|
Oct 17
2025 |
|
APDN
|
Joseph D. Ceccoli
Director |
BUY
Grant, award, or other acquisition
|
Direct | 22,511 Added 50.0% |
-
|
Oct 17
2025 |
|
AZO
|
Philip B. Daniele
President & CEO |
SELL
Open market or private sale
|
Direct | 2,533 Reduced 97.91% |
$10,187,295
$4021.83 p/Share
|
Oct 17
2025 |
|
AZO
|
Philip B. Daniele
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,533 Added 49.47% |
$1,487,200
$587.13 p/Share
|
Oct 17
2025 |
|
JBL
|
Mark T Mondello
Executive Chairman |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 3.08% |
$8,317,600
$207.94 p/Share
|
Oct 17
2025 |
|
HWC
|
John M Hairston
President & CEO |
SELL
Open market or private sale
|
Direct | 21,883 Reduced 7.47% |
$1,195,905
$54.65 p/Share
|
Oct 17
2025 |
|
HWC
|
Michael M Achary
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 9,894 Reduced 15.08% |
$542,784
$54.86 p/Share
|
Oct 17
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 11,592 Reduced 14.17% |
$662,250
$57.13 p/Share
|
Oct 17
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 11,592 Added 12.41% |
$95,865
$8.27 p/Share
|
Oct 17
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$929
$929.17 p/Share
|
Oct 17
2025 |
|
LEG
|
Lindsey Nicole Odaffer
EVP - Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 360 Added 0.61% |
$2,635
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Robert S Smith Jr
EVP, Pres. - Spec. and FF&T |
BUY
Grant, award, or other acquisition
|
Direct | 352 Added 0.35% |
$2,576
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Tammy M Trent
SVP - Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 176 Added 0.26% |
$1,288
$7.32 p/Share
|
Oct 17
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$2,027
$2.62 p/Share
|
Oct 17
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.3% |
$943
$2.62 p/Share
|
Oct 17
2025 |
|
LEG
|
Benjamin Michael Burns
Executive Vice President - CFO |
BUY
Grant, award, or other acquisition
|
Direct | 469 Added 0.33% |
$3,433
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Jennifer Joy Davis
EVP - GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct | 248 Added 0.29% |
$1,815
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Karl G Glassman
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 316 Added 0.03% |
$2,382
$7.54 p/Share
|
Oct 17
2025 |
|
LEG
|
James Tyson Hagale
EVP, Pres. - Bedding Products |
BUY
Grant, award, or other acquisition
|
Direct | 469 Added 0.33% |
$3,433
$7.32 p/Share
|
Oct 17
2025 |
|
LEG
|
Ryan Michael Kleiboeker
EVP-Chief Strategic Plan. Off. |
BUY
Grant, award, or other acquisition
|
Direct | 321 Added 0.37% |
$2,349
$7.32 p/Share
|
Oct 17
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect | 1,500 Reduced 0.0% |
$268,455
$178.97 p/Share
|
Oct 17
2025 |
|
ROIV
|
Eric Venker
President & Immunovant CEO |
SELL
Open market or private sale
|
Direct | 118,418 Reduced 7.29% |
$2,020,211
$17.06 p/Share
|
Oct 17
2025 |
|
ROIV
|
Eric Venker
President & Immunovant CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 118,418 Added 6.8% |
$1,876,925
$15.85 p/Share
|
Oct 17
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 244,203 Reduced 0.0% |
$33,844,093
$138.59 p/Share
|
Oct 17
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,371 Reduced 0.0% |
$2,546,036
$138.59 p/Share
|
Oct 17
2025 |
|
RTVA
|
Fred Aslan
President and CEO |
SELL
Open market or private sale
|
Direct | 25,500 Reduced 6.67% |
$153,000
$6.0 p/Share
|
Oct 17
2025 |
|
WAVD
|
Windsor Private Capital LP |
SELL
Open market or private sale
|
Indirect | 45,036 Reduced 0.0% |
$114,841
$2.55 p/Share
|
Oct 17
2025 |
|
WULF
|
Paul B. Prager
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 1,173,272 Added 0.0% |
-
|
Oct 17
2025 |
|
LXEO
|
Richard Nolan Townsend
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 13,133 Reduced 5.15% |
$121,480
$9.25 p/Share
|
Oct 17
2025 |
|
LXEO
|
Eric Adler
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,382 Reduced 4.41% |
$31,283
$9.25 p/Share
|
Oct 17
2025 |
|
LXEO
|
Jose Manuel Otero
Chief Technical Officer |
SELL
Open market or private sale
|
Direct | 2,115 Reduced 3.19% |
$19,563
$9.25 p/Share
|
Oct 17
2025 |
|
LXEO
|
Jenny Robertson
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,526 Reduced 4.87% |
$32,615
$9.25 p/Share
|
Oct 17
2025 |
|
LXEO
|
Tai Sandi See
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 3,888 Reduced 5.57% |
$35,964
$9.25 p/Share
|
Oct 17
2025 |
|
MRVL
|
Matthew J Murphy
Chairman of the Board and CEO |
SELL
Bona fide gift
|
Direct | 22,722 Reduced 8.16% |
-
|
Oct 17
2025 |
|
VOR
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect | 260,859 Reduced 0.0% |
$7,859,681
$30.13 p/Share
|
Oct 17
2025 |
|
ACI
|
Robert Bruce Larson
SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 17,815 Reduced 26.18% |
$351,846
$19.75 p/Share
|
Oct 17
2025 |
|
RBBN
|
Patrick W Macken
EVP, CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 9,252 Reduced 2.62% |
$35,250
$3.81 p/Share
|
Oct 17
2025 |
|
RBBN
|
Patrick W Macken
EVP, CLO & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 20,652 Added 5.53% |
-
|
Oct 17
2025 |